First Committee on Drugs Recommends Approval for Long-Acting Injectable Schizophrenia Treatment Xeplion

The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs recommended approval for a number of drugs including Janssen Pharmaceutical’s schizophrenia treatment Xeplion (paliperidone palmitate ester) and Santen Pharmaceutical’s fixed-dose combination eye drops for the treatment of glaucoma...read more